413 related articles for article (PubMed ID: 17048030)
21. [Bladder retraction, a complication of chemoprophylaxis of superficial bladder cancer using intravesical mitomycin C. Apropos of a case and review of the literature].
Punga-Maole ML; Hubert J; Mangin P
Prog Urol; 1995 Sep; 5(4):580-5. PubMed ID: 7581512
[TBL] [Abstract][Full Text] [Related]
22. Another negative chemoprevention trial: what can we learn?
Meyskens FL
Clin Cancer Res; 2008 Jan; 14(1):2-3. PubMed ID: 18172244
[No Abstract] [Full Text] [Related]
23. Chemoprevention of breast cancer among women at elevated risk as defined by Gail Score.
Micallef S; Micallef D; Schembri-Wismayer P; Brincat MP; Calleja-Agius J
Minerva Ginecol; 2015 Aug; 67(4):335-52. PubMed ID: 25668503
[TBL] [Abstract][Full Text] [Related]
24. Preventive effects of NSAIDs, NO-NSAIDs, and NSAIDs plus difluoromethylornithine in a chemically induced urinary bladder cancer model.
Nicastro HL; Grubbs CJ; Margaret Juliana M; Bode AM; Kim MS; Lu Y; You M; Milne GL; Boring D; Steele VE; Lubet RA
Cancer Prev Res (Phila); 2014 Feb; 7(2):246-54. PubMed ID: 24346344
[TBL] [Abstract][Full Text] [Related]
25. Reduced bladder cancer recurrence rate with cardioprotective aspirin after intravesical bacille Calmette-Guérin.
Gee JR; Jarrard DF; Bruskewitz RC; Moon TD; Hedican SP; Leverson GE; Nakada SY; Messing EM
BJU Int; 2009 Mar; 103(6):736-9. PubMed ID: 19007364
[TBL] [Abstract][Full Text] [Related]
26. Intravesical chemotherapy for carcinoma of the bladder--duration of the treatment course.
Jakse G
Prog Clin Biol Res; 1985; 185B():69-78. PubMed ID: 3898142
[No Abstract] [Full Text] [Related]
27. [Comparative study of thiotepa, adriamycin and cisplatin in the prophylaxis of recurrence of superficial bladder carcinoma in a group of 217 patients].
Llopis B; Gallego J; Boronat F; Moreno B; Mompó JA; Jiménez JF
Actas Urol Esp; 1986; 10(4):225-30. PubMed ID: 3092589
[No Abstract] [Full Text] [Related]
28. Current status of bladder cancer protocols in the EORTC Genito-Urinary Group.
Denis L; Pavone-Macaluso M; De Pauw M
Prog Clin Biol Res; 1984; 162B():429-39. PubMed ID: 6390450
[TBL] [Abstract][Full Text] [Related]
29. Breast cancer chemoprevention.
Gabriel EM; Jatoi I
Expert Rev Anticancer Ther; 2012 Feb; 12(2):223-8. PubMed ID: 22316370
[TBL] [Abstract][Full Text] [Related]
30. [Cytostatic topical therapy and prevention of recurrence in bladder papillomatosis].
Lunglmayr G
Wien Klin Wochenschr; 1971 Jul; 83(27):526-8. PubMed ID: 5001284
[No Abstract] [Full Text] [Related]
31. Antiproliferative and anti-inflammatory properties of diindolylmethane and lupeol against N-butyl-N-(4-hydroxybutyl) nitrosamine induced bladder carcinogenesis in experimental rats.
Prabhu B; Balakrishnan D; Sundaresan S
Hum Exp Toxicol; 2016 Jun; 35(6):685-92. PubMed ID: 26251508
[TBL] [Abstract][Full Text] [Related]
32. Chemoprevention of urological cancer.
Kamat AM; Lamm DL
J Urol; 1999 Jun; 161(6):1748-60. PubMed ID: 10332429
[TBL] [Abstract][Full Text] [Related]
33. Chemoprevention of breast cancer.
Files JA; Stan DL; Allen SV; Pruthi S
Womens Health (Lond); 2012 Nov; 8(6):635-46. PubMed ID: 23181529
[TBL] [Abstract][Full Text] [Related]
34. [Prevention of recurrence in urinary bladder cancer--quo vadis?].
Kriegmair M
Fortschr Med; 1989 Mar; 107(8):14-5. PubMed ID: 2707703
[No Abstract] [Full Text] [Related]
35. The search for the etiology of bladder cancer: are achievements sufficient?
Babjuk M
Eur Urol; 2009 Nov; 56(5):771-2; discussion 773-4. PubMed ID: 19635641
[No Abstract] [Full Text] [Related]
36. Intravesical chemoprophylaxis of superficial transitional cell carcinoma of the bladder. When should the drug be given?
Bouffioux C
Prog Clin Biol Res; 1985; 185B():47-55. PubMed ID: 4034591
[No Abstract] [Full Text] [Related]
37. Chemoprevention for bladder cancer.
Busby JE; Kamat AM
J Urol; 2006 Nov; 176(5):1914-20. PubMed ID: 17070211
[TBL] [Abstract][Full Text] [Related]
38. [Directed chemotherapy in superficial carcinoma conditioned by the knowledge of relapse factors].
Oliver F; Llopis B; Vera C; Domínguez C; Vidal J; Gallego J; Jiménez JF
Actas Urol Esp; 1988; 12(5):419-23. PubMed ID: 3218579
[No Abstract] [Full Text] [Related]
39. Randomized prospective phase III trial of difluoromethylornithine vs placebo in preventing recurrence of completely resected low risk superficial bladder cancer.
Messing E; Kim KM; Sharkey F; Schultz M; Parnes H; Kim D; Saltzstein D; Wilding G
J Urol; 2006 Aug; 176(2):500-4. PubMed ID: 16813878
[TBL] [Abstract][Full Text] [Related]
40. Prognostic effect of DNA aneuploidy from bladder washings in superficial bladder cancer.
Puntoni M; Zanardi S; Branchi D; Bruno S; Curotto A; Varaldo M; Bruzzi P; Decensi A
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):979-83. PubMed ID: 17507625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
